Help | Scores |Exit
Fragmin | Magnex | Solu Medrol
Esmolol Drug Name:  
A|B|C|D|E|F|G|H|I|K|L|M|N|O|P|Q|R|S|T|V|Z
Quick Dosage
Indications
Dosages
Interactions
Precautions
Contraindications
Adverse Reactions
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interactions:

Amiodarone

  • Adverse Effect: hypotension bradycardia or cardiac arrest  
  • Clinical Management: Monitor cardiac function carefully. Amiodarone should be used with caution in patients receiving beta blockers particularly if there is suspicion of underlying dysfunction of the sinus node such as bradycardia or sick sinus syndrome or if there is partial AV block.

    Amlodipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required monitor cardiac function carefully particularly in patients predisposed to heart failure.

    Benidipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required monitor cardiac function carefully particularly in patients predisposed to heart failure.

    Celecoxib

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Digoxin

  • Adverse Effect: AV block and possible digoxin toxicity  
  • Clinical Management: When beta blockers and digoxin are to be given concomitantly carefully monitor ECG and digoxin serum concentrations. Adjust doses accordingly.

    Diltiazem

  • Adverse Effect: Hypotension bradycardia AV conduction disturbances  
  • Clinical Management: If concurrent therapy is required monitor cardiac function carefully particularly in patients predisposed to heart failure. A dosage adjustment for hepatically metabolized beta blockers may be required.

    Felodipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required monitor cardiac function carefully particularly in patients predisposed to heart failure.

    Fentanyl

  • Adverse Effect: Severe hypotension  
  • Clinical Management: Concurrent use of a calcium channel blocker and a beta-adrenergic blocker during fentanyl anesthesia has been reported to result in severe hypotension.

    Flunarizine

  • Adverse Effect: Hypotension bradycardia and AV conduction disturbances  
  • Clinical Management: If concurrent therapy is required monitor cardiac function carefully particularly in patients predisposed to heart failure or bradyarrhythmias.

    Flurbiprofen

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Ibuprofen

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Ibuprofen Comb.

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Indomethacin

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Ketoprofen

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Ketorolac

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Lacidipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required monitor cardiac function carefully particularly in patients predisposed to heart failure.

    Lidoflazine

  • Adverse Effect: Hypotension bradycardia and AV conduction disturbances  
  • Clinical Management: If concurrent therapy is required monitor cardiac function carefully particularly in patients predisposed to heart failure or bradyarrhythmias.

    Mefenamic Acid

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Meloxicam

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Methyldopa

  • Adverse Effect: Exaggerated hypertensive response tachycardia or arrhythmias during physiologic stress or exposure to exogenous catecholamines  
  • Clinical Management: Monitor blood pressure carefully during concurrent therapy especially during excessive physiologic stress or use of exogenous catecholamines such as phenylpropanolamine.

    Morphine

  • Adverse Effect: Esmolol toxicity (bradycardia hypotension)  
  • Clinical Management: It is suggested that although morphine may elevate steady-state levels of esmolol any subsequent side effects can be titrated by lowering the esmolol infusion rate.

    Nabumetone

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Naproxen

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Nifedipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required monitor cardiac function carefully particularly in patients predisposed to heart failure.

    Nimesulide

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Nitrendipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required monitor cardiac function carefully particularly in patients predisposed to heart failure.

    Oxyphenbutazone

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Paracetamol

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Paracetamol Comb.

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Phenacetin

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Phenylbutazone

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Piroxicam

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Prazosin - BPH

  • Adverse Effect: An exaggerated hypotensive response to the first dose of the alpha blocker  
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required initiate the alpha blocker with a smaller than usual dose preferably at bedtime. Monitor the patient closely for hypotension.

    Tenoxicam

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Terazosin - BPH

  • Adverse Effect: An exaggerated hypotensive response to the first dose of the alpha blocker  
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required initiate the alpha blocker with a smaller than usual dose preferably at bedtime. Monitor the patient closely for hypotension.

    Verapamil

  • Adverse Effect: Hypotension bradycardia  
  • Clinical Management: If concurrent therapy is required monitor cardiac function carefully particularly in patients predisposed to heart failure.
  • EconazoleNitrate
    Edetatecalciumdisodium(calcium EDTA)
    EdetateDisodium(EDTA)
    Enalaprilat
    Ephedrine
    Epinephrine
    ErythromycinBase
    Ebastine
    Efavirenz
    Eicosapentanoic Acid
    Enalapril
    Enoxaparin
    Ergotamine
    Ephedrine-Nasal
    Epirubicin
    Ergometrine Maleate
    Erithrityl Tetranitrate
    Erythromycin - Topical
    Erythropoietin
    Esmolol
    Esomeprazole
    Ethambutol
    Ethacridine Lactate
    Ethamsylate
    Ethanolamine oleate
    Ethinyloestradiol
    Ethionamide
    Ethoheptazine
    Ethosuximide
    Ethyloestrenol
    Etidronate
    Etoposide
     
    Disclaimer